I did my doctorate at the Catalan Institute of Oncology, developing colorectal cancer models to study mechanisms of tumor progression. I got a predoctoral BEFI scholarship from ISCIII in 2003. The scientific production turned into 6 publications, including PNAS (2007, 2011), PLoS Biology (2011), British Journal of Cancer (2008), Molecular Carcinogenesis (2012) Molecular Cancer (2009). In April 2009 I joined the group of Dr. Cory Abate-Shen at Columbia University, New York, where I developed my current research in prostate cancer using genetically engeneered mouse models and and computational biology. Among my most relevant contributions are having generated the first complementary transcriptional interaction networks in cancer in humans and mice, and the consequent integration of both. For my postdoc I received a prestigious Marie Curie-IOF fellowship of the European Union in 2010. The results were published in PNAS (2013), Cancer Cell (2014) Cell Reports (2015) and numerous collaborations as reflected in publications with members in our laboratory [Cancer Research (2012a, 2012b), Science Translational Medicine (2013)] or other laboratories [Cancer Cell (2015)]. In July 2015 I was awarded a Miguel Servet type I Contract by the ISCIII and in August 2015 my first international project as Principal Investgador by the European Association of Urology Research Foundation. Since January 2016 I am a tenure-track investigator at IDIBELL.